Skip to evidence report

NEU.INH_VIP.develop_niche: Studies — page 7

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 122 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 6,001–7,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for NEU.INH_VIP.develop_niche
#Trait / studyIndividual trait IDMean IC score
6001IDP dMRI ProbtrackX FA fmaGCST900039350.03
6002Triglycerides in large VLDL (UKB data field 23501)GCST902695980.03
6003wg lh intensity-contrast parsopercularisGCST900038090.03
6004ERBB4/F3 ratioGCST903146900.03
6005ICD10 C53: Malignant neoplasm of cervix uteriGCST904542020.03
6006APOD levelsGCST904683370.03
6007Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T196ECGA0001960.03
6008CTSV levelsGCST904689170.03
6009PLA2G10 levelsGCST904702440.03
6010Diastolic blood pressureGCST904727770.03
6011Total concentration of branched-chain amino acids (leucine + isoleucine + valine)GCST900929840.03
6012Basal cell carcinomaGCST904681140.03
6013CRADD/EDAR ratioGCST903142350.03
6014Linoleic acid to total fatty acids percentageGCST905023320.03
6015Cholesteryl Esters to Total Lipids in Small VLDL percentageGCST904998000.03
6016WASL levelsGCST904710700.03
6017T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42)GCST903208610.03
6018aparc-DKTatlas rh volume pericalcarineGCST900029120.03
6019IDP dMRI TBSS ICVF Posterior limb of internal capsule RGCST900043450.03
6020Triglycerides in small HDL (UKB data field 23578)GCST902696750.03
6021IDP dMRI TBSS L1 Anterior corona radiata RGCST900040970.03
6022Seated height | Body size measuresUKBB000007630.03
6023Brainstem global volume PonsGCST900027650.03
6024CSF3R levelsGCST904688850.03
6025INPP5J levelsGCST904696180.03
6026Volume of right anterior amygdaloid areaGCST904750030.03
6027Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T268ECGA0002680.03
6028HBEGF levelsGCST902413920.03
6029Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T267ECGA0002670.03
6030T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39)GCST903208580.03
6031aparc-Desikan rh area isthmuscingulateGCST900031160.03
6032All influenzaFING000000640.03
6033Trigger fingerGCST901049070.03
6034PLXDC1 levelsGCST904702630.03
6035Androstenediol (3beta,17beta) monosulfate (1) levelsGCST901998720.03
6036Pelvic heightGCST904489120.03
6037aparc-a2009s rh area S-calcarineGCST900034140.03
6038X-14626 levelsGCST902438610.03
6039IGSF8 levelsGCST904695400.03
6040ZP3 levelsGCST904711050.03
6041Anemia in chronic kidney disease (PheCode 285.21)GCST904757920.03
6042PALM levelsGCST904701540.03
6043DBNL levelsGCST904689510.03
6044aseg global intensity 4th-VentricleGCST900037520.03
6045Valine levels (UKB data field 23467)GCST902695640.03
6046SPARCL1 levelsGCST902428700.03
6047Whole body fat free mass (UKB data field 23101)GCST904281200.03
6048Treatment or medication use - insulin product (UKB data field 20003_1140883066)GCST900422260.03
6049HippSubfield rh volume Whole-hippocampal-headGCST900027100.03
6050CLEC1B/PLXNA4 ratioGCST903141000.03
6051Valine levelsGCST901327520.03
6052Provencibacterium massiliense abundance in stoolGCST900325270.03
6053Volume of left accessory basal nucleusGCST904749400.03
6054Moderate visual impairment, binocularFING000008310.03
6055T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 32)GCST903205950.03
6056Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)FING000003160.03
6057TAX1BP3 levelsGCST902429760.03
6058RSPO3 levelsGCST904705040.03
6059TIE1 levelsGCST904708630.03
6060MFAP5 levelsGCST904698990.03
6061T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 30)GCST903208490.03
6062DKK4/REG1B ratioGCST903144900.03
6063Type 2 diabetesGCST900860710.03
6064CD74/NPDC1 ratioGCST903138950.03
6065IDP T1 FAST ROIs R subcallosal cortexGCST900025040.03
6066Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T154ECGA0001540.03
6067CRADD/HSPA1A ratioGCST903142390.03
6068Breast cancer | neoplasmsUKBB000001090.03
6069Subclinical hypothyroidism in pregnancyGCST904351970.03
6070Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T210ECGA0002100.03
6071Primary gonarthrosis, bilateralFING000012130.03
6072Incisional hernia (PheCode 550.6)GCST904760640.03
6073Cholesterol in Small VLDLGCST904997460.03
6074Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T166ECGU0001660.03
6075Separation of retinal layers (serosa)FING000012920.03
6076Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T271ECGU0002710.03
6077Right-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivityGCST903028160.03
6078Cholesterol in Medium HDLGCST904984950.03
6079Varicose veinsFING000014160.03
6080Systolic blood pressureGCST900259680.03
6081CNTN1 levelsGCST904688030.03
6082TBL1X levelsGCST904708150.03
6083HypertensionFING000006370.03
6084NUCB2/TXNDC5 ratioGCST903155780.03
6085TDGF1 levelsGCST904708240.03
6086Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T209ECGU0002090.03
6087Endometriosis diagnosis and infertility diagnosis occurring togetherFING000004990.03
6088ADGRB3 levelsGCST904682340.03
6089FABP4 levelsGCST900120750.03
6090Cerebrospinal fluid S-1-pyrroline-5-carboxylate levelsGCST903182350.03
6091wg lh intensity-contrast lateralorbitofrontalGCST900038030.03
6092CD84/F2R ratioGCST903139120.03
6093GGT1/MME ratioGCST903149300.03
6094Cancer of prostate (PheCode 185)GCST904755910.03
6095Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T140ECGA0001400.03
6096NPHS1 levelsGCST904700700.03
6097Internal derangement of kneeFING000006840.03
6098Macular degenerationGCST904753860.03
6099DTI autoptx MD ilf r tractGCST903852350.03
6100Prostate cancerGCST902747160.03
6101DTI TBSS L1 Posterior thalamic radiation LGCST903844570.03
6102Diabetes (standard GWA)GCST902672780.03
6103IDP SWI T2star left pallidumGCST900038690.03
6104Gamma glutamyl transferase levelsGCST902786300.03
6105aseg rh volume CerebralWhiteMatterGCST900026320.03
6106Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T87ECGA0000870.03
6107Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T162ECGA0001620.03
6108B2M levelsGCST904684090.03
6109Phospholipids to total lipids ratio in small LDLGCST900929650.03
6110IDP dMRI TBSS ICVF Tapetum RGCST900043730.03
6111APOM/ERBB3 ratioGCST903133140.03
6112Autorefraction - 3mm cylindrical power angle (left) | EyesightUKBB000000640.03
6113AHSP/CA2 ratioGCST903132150.03
6114Treatment/medication code - levothyroxine sodium | MedicationsUKBB000008490.03
6115Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T240ECGA0002400.03
6116Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T157ECGA0001570.03
6117Urinary ethanolamine to urinary creatinine ratioGCST904517170.03
6118T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47)GCST903208660.03
6119Type 2 diabetes, definitions combinedFING000013820.03
6120Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T74ECGU0000740.03
6121CPB2 levelsGCST904688400.03
6122Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T265ECGU0002650.03
6123Mouth/teeth dental problems - Mouth ulcers | MouthUKBB000004880.03
6124GlaucomaGCST904753830.03
6125Prescriptions - amlodipine | calcium channel blocker,dihydropyridine,anti-hypertensiveUKBB000006600.03
6126Cough on most days | Medical informationUKBB000001530.03
6127Excessive scarringGCST904833680.03
6128Physical function (baseline)GCST905658370.03
6129CEBPB/NADK ratioGCST903140060.03
6130GlaucomaGCST904758690.03
6131Basal cell carcinomaGCST900134100.03
6132Paradoxical eczema in biologic-treated plaque psoriasisGCST901625500.03
6133Cholesteryl esters to total lipids in very large HDL percentage (UKB data field 23631)GCST902697280.03
6134Height, inverse-rank normalizedFING000006070.03
6135SUMF1 levelsGCST904707830.03
6136Peripheral vascular diseaseGCST900861340.03
6137Operation code - carpal tunnel surgery | OperationsUKBB000005530.03
6138Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T161ECGA0001610.03
6139aparc-a2009s lh thickness S-cingul-MarginalisGCST900036480.03
6140NPC2 levelsGCST904700680.03
6141ADAMTS15/SULT2A1 ratioGCST903131710.03
6142Phospholipids in large VLDL (UKB data field 23497)GCST902695940.03
6143DLL1/IL18BP ratioGCST903144950.03
6144DAG1/GP6 ratioGCST903143750.03
6145Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T254ECGU0002540.03
6146IDP dMRI TBSS L2 Pontine crossing tractGCST900041240.03
6147IDP dMRI ProbtrackX ISOVF ilf lGCST900045390.03
6148Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731)GCST904762460.03
6149IL10 levelsGCST904695460.03
6150Right-hemisphere visual network to hippocampus white-matter structural connectivityGCST903027850.03
6151Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T252ECGA0002520.03
6152MAP3K5 levelsGCST904698540.03
6153IDP dMRI TBSS ISOVF Posterior thalamic radiation RGCST900045050.03
6154ESM1 levelsGCST900120680.03
6155BCAN/KLK6 ratioGCST903134790.03
6156SERPINB6 levelsGCST904705910.03
6157Androstenediol (3beta,17beta) disulfate (2) levelsGCST901998510.03
6158T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 10)GCST903208290.03
6159Average diameter for VLDL particles (UKB data field 23431)GCST902695280.03
6160Right-hemisphere visual network to caudate white-matter structural connectivityGCST903027820.03
6161Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T270ECGA0002700.03
6162aparc-DKTatlas rh area lateraloccipitalGCST900032740.03
6163Interpolated Year when non-cancer illness first diagnosed | Medical conditionsUKBB000003710.03
6164Volume of left paralaminar nucleusGCST904749820.03
6165aparc-DKTatlas rh area pericalcarineGCST900032840.03
6166Mean corpuscular haemoglobin | Blood countUKBB000004470.03
6167Diastolic blood pressureGCST904727790.03
6168Acute pancreatitisGCST900185690.03
6169Cholesteryl esters in large VLDL (UKB data field 23499)GCST902695960.03
6170Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T160ECGA0001600.03
6171Phenylacetylcarnitine levelsGCST901999930.03
6172Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T441ECGU0004410.03
6173T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 14)GCST903205770.03
6174Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T23ECGA0000230.03
6175Diabetes mellitus | endocrine/metabolicUKBB000001690.03
6176T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 34)GCST903205970.03
6177Modified Stumvoll Insulin Sensitivity IndexGCST902675740.03
6178T1 FreeSurfer a2009s rh G cuneus areaGCST903849000.03
6179Otitis media and Eustachian tube disorders (PheCode 381)GCST904759020.03
6180Left-hemisphere default mode network to amygdala white-matter structural connectivityGCST903027720.03
6181Height (baseline)GCST905658430.03
6182Sphingomyelin (d18:1/16:0) levelsGCST900257440.03
6183Exophthalmic conditionsFING000005260.03
6184Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T266ECGA0002660.03
6185Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T161ECGU0001610.03
6186LGALS4/PCDH17 ratioGCST903153150.03
6187IDP dMRI TBSS L2 Uncinate fasciculus RGCST900041670.03
6188Peak expiratory flow (PEF) | SpirometryUKBB000006380.03
6189GRAP2/PLPBP ratioGCST903149840.03
6190Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T242ECGA0002420.03
6191Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T146ECGA0001460.03
6192Lichen sclerosus et atrophicusFING000007230.03
6193REST UKBBICA NET100 1287GCST903871410.03
6194Colonic or urogenital fistulaFING000003150.03
6195ICD10 O24.4: Diabetes mellitus arising in pregnancyGCST904542360.03
6196eGFR in diabetes mellitus (loose) kidney healthy controls (minimal adjustment)GCST906247780.03
6197IDP dMRI TBSS ISOVF Sagittal stratum RGCST900045070.03
6198Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T158ECGU0001580.03
6199Volume of right medial nucleusGCST904750420.03
6200RAPGEF2 levelsGCST904704260.03
6201Colon cancer (PheCode 153.2)GCST904755670.03
6202CASP8 levelsGCST904685480.03
6203magnesium (Mg, maximum, inv-norm transformed)GCST904754770.03
6204Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T144ECGU0001440.03
6205HeightGCST903028900.03
6206Maternal care for other conditions predominantly related to pregnancyFING000007910.03
6207ConjunctivitisFING000003460.03
6208CALCOCO1/DCTN1 ratioGCST903136000.03
6209Femur length to body height ratioGCST902702560.03
6210T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 8)GCST903208270.03
6211TRIM24 levelsGCST904709650.03
6212Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T168ECGA0001680.03
6213Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T460ECGU0004600.03
6214Levulinate 4-oxovalerate levelsGCST902435450.03
6215Triglycerides in very large VLDLGCST905006710.03
6216Cholesteryl esters to total lipids ratio in small VLDLGCST900929710.03
6217aparc-Desikan rh volume parsopercularisGCST900028180.03
6218Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T139ECGA0001390.03
6219Other (seronegative) rheumatoid arthritis, wideFING000009170.03
6220BAX levelsGCST904684240.03
6221ENPP7 levelsGCST904691180.03
6222ERBB4/UMOD ratioGCST903146920.03
6223Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T195ECGA0001950.03
6224Medication use (salicylic acid and derivatives)GCST900187750.03
6225Hyperplasia of prostate (PheCode 600)GCST904761530.03
6226FCRL2/SEMA7A ratioGCST903148000.03
6227Alanine levelsGCST900928060.03
6228GLOD4/S100A4 ratioGCST903149440.03
6229Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T433ECGU0004330.03
6230LACRT levelsGCST904697250.03
6231Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T116ECGU0001160.03
6232Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)GCST902697240.03
6233HBEGF/PLXNA4 ratioGCST903150360.03
6234Eosinophil countGCST900187330.03
6235CFB levelsGCST904687230.03
6236RHOC levelsGCST904704670.03
6237Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T147ECGA0001470.03
6238Volume of right central nucleusGCST904749160.03
6239Valine levelsGCST900929950.03
6240Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T270ECGU0002700.03
6241MAPK9 levelsGCST904698570.02
6242CRTAM/GZMA ratioGCST903142750.02
6243CWC15 levelsGCST904689200.02
6244rfMRI connectivity ICA-features 4GCST900063420.02
6245Volume of right whole amygdalaGCST904749310.02
6246hemoglobin (mean, inv-norm transformed)GCST904753740.02
6247KCTD5 levelsGCST904696700.02
6248Triglycerides in very small VLDLGCST905008850.02
6249ICA1/MVK ratioGCST903151080.02
6250Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T215ECGU0002150.02
6251COL6A3 levelsGCST904688210.02
6252TNFRSF4/TNFRSF9 ratioGCST903159390.02
6253Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17ECGA0000170.02
6254CX3CL1 levelsGCST902412040.02
6255S100A12 levelsGCST904705130.02
6256Left-hemisphere somatomotor network to thalamus white-matter structural connectivityGCST903026820.02
6257Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T273ECGU0002730.02
6258GP2/LGALS4 ratioGCST903149600.02
6259VWC2L levelsGCST904710630.02
6260Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T159ECGA0001590.02
6261Age-related macular degeneration (whether dry or wet)FING000000470.02
6262Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T178ECGU0001780.02
6263Left-hemisphere limbic network to putamen white-matter structural connectivityGCST903027380.02
6264SUMF2 levelsGCST904707840.02
6265Autorefraction - 3mm weak meridian angle (left) | EyesightUKBB000000710.02
6266aparc-a2009s lh volume G-cingul-Post-ventralGCST900029340.02
6267Omega-3 fatty acids to total fatty acids percentageGCST905020900.02
6268X-23641 levelsGCST902006030.02
6269BST1 levelsGCST904684740.02
6270LY6D/NECTIN4 ratioGCST903153440.02
6271Breast cancer (PheCode 174)GCST904356000.02
6272ALB levelsGCST902695760.02
6273PIK3IP1/TNFRSF1B ratioGCST903156540.02
6274CRELD1 levelsGCST904688580.02
6275ADH4/DCXR ratioGCST903131900.02
6276CD302/CD99 ratioGCST903138050.02
6277AGXT/MME ratioGCST903132070.02
6278Prevotella sp000434975 abundance in stoolGCST900325180.02
6279Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T253ECGA0002530.02
6280PENK levelsGCST904702080.02
6281OsteoporosisGCST904681450.02
6282Thyroid problemsGCST904752760.02
6283Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T13ECGU0000130.02
6284Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T209ECGA0002090.02
6285ACYP2 levelsGCST902401870.02
6286total creatine kinase (minimum, inv-norm transformed)GCST904764160.02
6287BCAT1 levelsGCST904684270.02
6288First line medication for Crohn's diseaseFING000005440.02
6289CST3/RETN ratioGCST903142970.02
6290Disorders of choroid and retinaFING000004380.02
6291Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T142ECGA0001420.02
6292Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T212ECGA0002120.02
6293IDP T1 FAST ROIs L planum temporaleGCST900025410.02
6294Ankle spacing width | Bone-densitometry of heelUKBB000000350.02
6295T1 FreeSurfer BA rh V2 exvivo areaGCST903855570.02
6296aparc-Desikan lh volume lingualGCST900027800.02
6297Right-hemisphere limbic network to caudate white-matter structural connectivityGCST903028280.02
6298Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T243ECGA0002430.02
6299Prostate cancerGCST900118080.02
6300Left-hemisphere control network to amygdala white-matter structural connectivityGCST903027570.02
6301Osteopathies and chondropathiesFING000009130.02
6302ThalamNuclei lh volume VAmcGCST900027230.02
6303IPCEF1/SPARC ratioGCST903151860.02
6304LPO levelsGCST904697890.02
6305wg lh intensity-contrast insulaGCST900038260.02
6306N6,N6-dimethyllysine levels in chronic kidney diseaseGCST902575290.02
6307Total lipids in large HDL (UKB data field 23559)GCST902696560.02
6308CPM levelsGCST904688430.02
6309Cyst of kidney, acquired (PheCode 586.2)GCST904761330.02
6310LAT/PLXNA4 ratioGCST903152860.02
6311Volume of right central nucleusGCST904750270.02
6312T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4)GCST903205670.02
6313GLRX5 levelsGCST904693610.02
6314CCL5/TACC3 ratioGCST903137070.02
6315Standing height (UKB data field 50)GCST904681780.02
6316ENO2/TXNDC5 ratioGCST903146710.02
6317Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T434ECGU0004340.02
6318SPINK6 levelsGCST904707250.02
6319Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T68ECGU0000680.02
6320IDP dMRI TBSS L2 External capsule RGCST900041550.02
6321MGLL/PLA2G4A ratioGCST903154390.02
6322ICD10 C61: Malignant neoplasm of prostateGCST900438940.02
6323AXIN1/INPPL1 ratioGCST903134100.02
6324aparc-Desikan rh volume insulaGCST900028340.02
6325Otitis media (PheCode 381.1)GCST904759030.02
6326LMNB2 levelsGCST904697820.02
6327Medication use (vasodilators used in cardiac diseases)GCST900187630.02
6328Standing height | Body size measuresUKBB000007960.02
6329Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)FING000007550.02
6330COCH levelsGCST904688100.02
6331Citrate levels (UKB data field 23473)GCST902695700.02
6332Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T176ECGU0001760.02
6333CD244/FCRL6 ratioGCST903137650.02
6334T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83)GCST903209020.02
6335Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T205ECGA0002050.02
6336T1 FreeSurfer DK rh lateraloccipital areaGCST903856990.02
6337Total triglycerides levels (UKB data field 23407)GCST902695040.02
6338Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T154ECGU0001540.02
6339Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T22ECGA0000220.02
6340CLEC1B/MGLL ratioGCST903140970.02
6341Phospholipids in small LDLGCST904996810.02
6342Ascending aorta diameterGCST902673900.02
6343ThalamNuclei lh volume VPLGCST900027170.02
6344DTI autoptx L1 cst r tractGCST903851480.02
6345IGLC2 levelsGCST904695360.02
6346Cancer of urinary organs (incl. kidney and bladder) (PheCode 189)GCST904755930.02
6347QC SWI-to-T1 linear alignment discrepancyGCST900063520.02
6348Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T255ECGA0002550.02
6349IL22 levelsGCST900880660.02
6350DTI autoptx MD ifo r tractGCST903852330.02
6351ABHD14B/SPARC ratioGCST903131460.02
6352Operation code - bunion/hallus valgus surgery | OperationsUKBB000005510.02
6353Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T10ECGU0000100.02
6354EIF4G1/HEXIM1 ratioGCST903146350.02
6355ADGRG2 levelsGCST904682410.02
6356Bicarbonate (mean, inv-norm transformed)GCST904751480.02
6357ThalamNuclei rh volume VAmcGCST900027470.02
6358Total lipids in medium VLDL (UKB data field 23503)GCST902696000.02
6359aseg global volume Brain-StemGCST900026020.02
6360Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T25ECGA0000250.02
6361Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T141ECGA0001410.02
6362severe traumatic brain injury, does not include concussionFING000013000.02
6363aparc-pial rh area pericalcarineGCST900031940.02
6364Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T272ECGU0002720.02
6365Type 1 diabetesGCST900187050.02
6366CKAP4/IL4R ratioGCST903140720.02
6367ArthrosisFING000001110.02
6368PNLIPRP1 levelsGCST904702730.02
6369ELOA/MAD1L1 ratioGCST903146400.02
6370Concentration of very large VLDL particles (UKB data field 23488)GCST902695850.02
6371TNFRSF11B levelsGCST904709030.02
6372Phenylacetylglutamate levelsGCST902000690.02
6373CETN3 levelsGCST904687220.02
6374IDP dMRI TBSS OD Superior corona radiata RGCST900044260.02
6375Total lipids in very large VLDL (UKB data field 23489)GCST902695860.02
6376Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T182ECGU0001820.02
6377HSPB1 levelsGCST901793170.02
6378DAG1/PLA2G4A ratioGCST903143800.02
6379Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T138ECGA0001380.02
6380SLC5A8 levelsGCST902428500.02
6381DFFA/SIRT2 ratioGCST903144620.02
6382BA-exvivo rh area V1GCST900032300.02
6383Triglycerides in very large VLDL (UKB data field 23494)GCST902695910.02
6384STK11/USP8 ratioGCST903158920.02
6385Birth size (multivariate analysis)GCST906241010.02
6386ARHGAP1/SPARC ratioGCST903133440.02
6387FGF19/SCG2 ratioGCST903148090.02
6388Skin cancerGCST904751890.02
6389Omega-3 fatty acid levelsGCST905024240.02
6390ICD10 O42: Premature rupture of membranesGCST904542380.02
6391Body size (confirmatory factor analysis Factor 21)GCST903093550.02
6392X-21441 levelsGCST902005810.02
6393CNTNAP2/DPP10 ratioGCST903141670.02
6394ICAM2/IL7R ratioGCST903151170.02
6395TNXB levelsGCST904709300.02
6396ACHE levelsGCST904681990.02
6397Impacted cerumen (PheCode 380.4)GCST904759010.02
6398Brainstem global volume Whole-brainstemGCST900027680.02
6399Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T267ECGU0002670.02
6400DBNL/PDGFB ratioGCST903144220.02
6401Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12ECGA0000120.02
6402Medication for pain relief, constipation, heartburn - Laxatives (e.g. Dulcolax, Senokot) | MedicationUKBB000004560.02
6403Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T35ECGA0000350.02
6404HeightGCST902786370.02
6405SPINT1/SUSD2 ratioGCST903158780.02
6406Hydrocele (PheCode 603.1)GCST904761570.02
6407Diverticulosis and diverticulitis (PheCode 562)GCST904760730.02
6408Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T177ECGU0001770.02
6409Eye problems/disorders - None of the above | EyesightUKBB000002320.02
6410CCDC50 levelsGCST904685610.02
6411PPCDC/RWDD1 ratioGCST903157040.02
6412Cholesteryl esters in very large VLDL (UKB data field 23492)GCST902695890.02
6413HLA-DRA levelsGCST904694580.02
6414Diaphragmatic hernia (PheCode 550.2)GCST904760610.02
6415Spermatocele (PheCode 603.2)GCST904761580.02
6416Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T158ECGA0001580.02
6417Takes medication for Thyroid problems?GCST904752770.02
6418CPB1/CTRC ratioGCST903142090.02
6419BLNK levelsGCST904684480.02
6420CholecystectomyFING000002730.02
6421Left-hemisphere visual network to left-hemisphere control network white-matter structural connectivityGCST903026530.02
6422Sleep disorders | neurologicalUKBB000007760.02
6423Forced expiratory volume (baseline)GCST905658440.02
6424aparc-DKTatlas lh volume lingualGCST900028730.02
6425CTBS levelsGCST904689000.02
6426Coxarthrosis, primary, with hip surgeryFING000003640.02
6427Total body bone mineral density (age 45-60)GCST0053500.02
6428GUCA2A/LGALS4 ratioGCST903149980.02
6429CLPP/DECR1 ratioGCST903141370.02
6430Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T239ECGU0002390.02
6431Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T498ECGA0004980.02
6432HBEGF/WWP2 ratioGCST903150380.02
6433IDP dMRI TBSS ICVF Uncinate fasciculus RGCST900043710.02
6434UCMA levelsGCST902432850.02
6435DVT of lower extremitiesFING000004820.02
6436Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T190ECGA0001900.02
6437PIK3IP1/TNFRSF1A ratioGCST903156530.02
6438Urine GlcNAc sulfate conjugate of C21H34O2 steroid** levels in chronic kidney diseaseGCST902651750.02
6439DAB2/LYN ratioGCST903143650.02
6440ESAM/SCARF1 ratioGCST903147150.02
6441LPO levelsGCST902417300.02
6442aparc-DKTatlas lh area fusiformGCST900032390.02
6443CLEC14A/PTPRS ratioGCST903140810.02
6444T1 FreeSurfer DK lh MeanThickness thicknessGCST903856560.02
6445ALDH1A1 levelsGCST904682800.02
6446Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T254ECGA0002540.02
6447PLXNB2/SEMA7A ratioGCST903156920.02
6448CFHR4 levelsGCST904687270.02
6449PAPPA levelsGCST900120360.02
6450IGF1 levelsGCST900259890.02
6451Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levelsGCST902001180.02
6452THTPA levelsGCST904708600.02
6453Non-cancer illness code, self-reported - migraine | Medical conditionsUKBB000005200.02
6454Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T442ECGU0004420.02
6455FUT8/RSPO1 ratioGCST903148910.02
6456HYAL1 levelsGCST904694950.02
6457RGMA/RGMB ratioGCST903157690.02
6458Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6ECGU0000060.02
6459Aneurysms, operations, SAHFING000000850.02
6460DTI TBSS MD Tapetum LGCST903846190.02
6461T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26)GCST903205890.02
6462Urine glycocholenate sulfate* levels in chronic kidney diseaseGCST902652920.02
6463FLT1 levelsGCST904692490.02
6464Asthma (only as main-diagnosis) (more control exclusions)FING000001140.02
6465Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16ECGA0000160.02
6466PSTPIP2 levelsGCST904703660.02
6467HYOU1/THBD ratioGCST903151060.02
6468Total bilirubin levels (UKB data field 30840)GCST904681040.02
6469LAMB1 levelsGCST904697320.02
6470PNLIPRP2 levelsGCST904702740.02
6471Use of disulfiram, acamprosate or naltrexoneFING000014100.02
6472IL18BP/THBD ratioGCST903151560.02
6473CPA1/PRSS2 ratioGCST903142060.02
6474Cholesteryl Esters to Total Lipids in Small HDL percentageGCST904994060.02
6475Skin elastin (cheek, R5)GCST905027870.02
6476Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T72ECGU0000720.02
6477wg lh intensity-contrast inferiortemporalGCST900038000.02
6478Sleep disorders | Episodic and paroxysmal disordersUKBB000007750.02
6479PRSS2 levelsGCST902431260.02
6480Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T24ECGA0000240.02
6481Volume of right basal nucleusGCST904749100.02
6482Triglyceride levels (MTAG)GCST901791490.02
6483DTI autoptx L1 atr l tractGCST903851410.02
6484Non-cancer illness code, self-reported - glaucoma | Medical conditionsUKBB000005110.02
6485Free cholesterol in medium LDLGCST904987670.02
6486LSIL lesion of the cervix uteri, vagina or vulvaFING000007330.02
6487Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T208ECGU0002080.02
6488Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T150ECGU0001500.02
6489ADGRE5/GAS6 ratioGCST903131790.02
6490Right-hemisphere default mode network to caudate white-matter structural connectivityGCST903028450.02
6491Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T264ECGU0002640.02
6492Triglyceride to HDL cholesterol ratioGCST902959500.02
6493Inguinal hernia, bilateralFING000006820.02
6494PSPN levelsGCST904703640.02
6495Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T42ECGA0000420.02
6496Mean sphered cell volume | Blood countUKBB000004520.02
6497BCAN/CD200 ratioGCST903134770.02
6498IL1R2 levelsGCST904695720.02
6499Pure hyperglyceridaemiaFING000012310.02
6500IL17RB levelsGCST904695630.02
6501IL4R levelsGCST904695980.02
6502EFNA4/VWC2 ratioGCST903146070.02
6503Alpha angleGCST901296350.02
6504LDL cholesterolGCST900187410.02
6505aparc-DKTatlas rh volume cuneusGCST900028960.02
6506Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T14ECGU0000140.02
6507BSG/LY9 ratioGCST903135340.02
6508CXCL11/CXCL13 ratioGCST903143330.02
6509Glucosamine medicationFING000005840.02
6510ACAA1 levelsGCST904681930.02
6511SRPX levelsGCST904707440.02
6512TNFSF10 levelsGCST900120110.02
6513T1 CAT volume L VIIIbGCST903841300.02
6514FEV1GCST0074320.02
6515Tachycardia NOS (PheCode 427.7)GCST904759790.02
65161,5-anhydroglucitol (1,5-ag) levelsGCST902435290.02
6517Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T207ECGA0002070.02
6518Hand grip strength (right) | Hand grip strengthUKBB000003010.02
6519Pregnenetriol disulfate levelsGCST902002380.02
6520aparc-Desikan rh volume lateraloccipitalGCST900028110.02
6521FCRL2/TNFRSF13B ratioGCST903148010.02
6522Eosinophil count varianceGCST905656890.02
6523TFF1 levelsGCST904708350.02
6524Operation code - varicose vein surgery | OperationsUKBB000005680.02
6525Pulse pressure (BMI unadjusted)GCST903351660.02
6526Hair colour (natural, before greying) - Blonde | Sun exposureUKBB000002960.02
6527Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T500ECGA0005000.02
6528Cholesteryl Esters in Medium HDLGCST904985320.02
6529T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64)GCST903206270.02
6530wg lh intensity-contrast banksstsGCST900037930.02
6531Anti-human herpes virus 6 IE1A IgG seropositivityGCST900069030.02
6532Venous thromboembolismFING000014270.02
6533Disorders of muscle, ligament, and fascia | musculoskeletalUKBB000001870.02
6534TDRKH levelsGCST904708270.02
6535CXCL10/CXCL11 ratioGCST903143300.02
6536EGLN1/PSIP1 ratioGCST903146200.02
6537Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T198ECGA0001980.02
6538REN levelsGCST900120380.02
6539Type 2 diabetes | endocrine/metabolicUKBB000008670.02
6540CCN2/SPINT2 ratioGCST903137160.02
6541Haemorrhoids and perianal venous thrombosisFING000005990.02
6542aparc-Desikan rh volume pericalcarineGCST900028210.02
6543Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T69ECGU0000690.02
6544Retinal detachments and breaksFING000012600.02
6545wg rh intensity-contrast inferiortemporalGCST900038350.02
6546Left-hemisphere visual network to left-hemisphere visual network white-matter structural connectivityGCST903026480.02
6547Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T499ECGA0004990.02
6548Phosphoglycerides levels (UKB data field 23434)GCST902695310.02
6549BRK1 levelsGCST904684690.02
6550Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451ECGU0004510.02
6551Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T82ECGA0000820.02
6552T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3)GCST903208220.02
6553T1 FreeSurfer aseg 4th-VentricleGCST903841480.02
6554Cryptic phenotype that captures autosomal dominant polycystic kidney disease severityGCST901018290.02
6555Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T165ECGA0001650.02
6556aparc-pial lh area cuneusGCST900031450.02
6557APCS levelsGCST904284630.02
6558Ankle spacing width (right) | Bone-densitometry of heelUKBB000000340.02
6559Placental weight (maternal genotype, adjusted for sex and gestational age)GCST902751900.02
6560Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T271ECGA0002710.02
6561FVCGCST902786290.02
6562CD40 levelsGCST904686330.02
6563GRAP2/MAP4K5 ratioGCST903149820.02
6564Seropositive rheumatoid arthritis, strict definitionFING000012970.02
6565EDAR/TREML2 ratioGCST903145920.02
6566ENO2/HCLS1 ratioGCST903146600.02
6567Pulse pressureGCST900187500.02
6568aparc-Desikan rh area lateraloccipitalGCST900031170.02
6569Breast cancer (estrogen-receptor negative)GCST0050760.02
6570CD27/TGFBR2 ratioGCST903137760.02
6571Hippocampal subfield left CA4 volume (head)GCST902679430.02
6572Melanocytic naevi, other sites/unspecifiedFING000008020.02
6573Volume of left anterior amygdaloid areaGCST904748710.02
6574Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T163ECGA0001630.02
6575DDC levelsGCST904689670.02
6576Diacylglycerol_32:2_[M+H-H2O]1+ levelsGCST900601680.02
6577Human herpes virus 7 U14 antibody levelsGCST900069090.02
6578hematocrit (minimum, inv-norm transformed)GCST904753440.02
6579T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 12)GCST903208310.02
6580Psoas tendinitisFING000012210.02
6581QDPR/THOP1 ratioGCST903157570.02
6582Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T497ECGA0004970.02
6583BA-exvivo rh volume V1GCST900028580.02
6584S100A11/SERPINB8 ratioGCST903157990.02
6585Phospholipids to total lipids in large LDL percentage (UKB data field 23614)GCST902697110.02
6586Age-related macular degenerationGCST900861110.02
6587aparc-DKTatlas lh area lingualGCST900032450.02
6588Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905021550.02
6589CholecystitisFING000002740.02
6590Cancer of prostate (PheCode 185)GCST900418530.02
6591aparc-Desikan lh thickness cuneusGCST900034490.02
6592Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T244ECGA0002440.02
6593SEMA4D levelsGCST904705730.02
6594Free cholesterol in large HDL (UKB data field 23563)GCST902696600.02
6595Cholesterol to Total Lipids in Small HDL percentageGCST904993730.02
6596Enlarged prostate (Benign prostatic hyperplasia)GCST904752610.02
6597T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3)GCST903205660.02
6598GAS6/NOTCH1 ratioGCST903149180.02
6599Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T249ECGU0002490.02
6600THBS2 levelsGCST904708540.02
6601Heart attackGCST904681320.02
6602ORM1 levelsGCST904701290.02
6603Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T197ECGA0001970.02
6604Skin color (cheek, B value)GCST905027790.02
6605T1 FreeSurfer BA rh V2 exvivo thicknessGCST903855710.02
6606Pulse pressureGCST903017020.02
6607potassium (minimum, inv-norm transformed)GCST904763100.02
6608Facial wrinkles (under eye)GCST900949030.02
6609SF3B4/SIRT2 ratioGCST903158380.02
6610red cell diameter width (RDW, minimum, inv-norm transformed)GCST904763650.02
6611AXIN1/BACH1 ratioGCST903134000.02
6612Pregnenetriol sulfate levelsGCST902002410.02
6613MYOC levelsGCST904228250.02
6614Disorder of skin and subcutaneous tissue NO (PheCode 689)GCST904761690.02
6615Noninfective enteritis and colitisFING000008810.02
6616Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T167ECGA0001670.02
6617Benign neoplasm of skin (PheCode 216)GCST904756200.02
6618PRKAR1A/SNAP23 ratioGCST903157280.02
6619Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney diseaseGCST902660160.02
6620Diabetic retinopathy (PheCode 250.7)GCST904756890.02
6621Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T86ECGA0000860.02
6622Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181ECGU0001810.02
6623Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T71ECGU0000710.02
6624Fasciitis | musculoskeletalUKBB000002390.02
6625IDUA levelsGCST904695080.02
6626GlaucomaGCST900186320.02
6627NTN1 levelsGCST902420470.02
6628CD8A levelsGCST904686550.02
6629FYB1/MESD ratioGCST903149110.02
6630Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T160ECGU0001600.02
6631aseg rh intensity PutamenGCST900037840.02
6632T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 31)GCST903208500.02
6633MGLL/STK4 ratioGCST903154430.02
6634Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T280ECGA0002800.02
6635Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T248ECGU0002480.02
6636Myocardial infarction, strictFING000008520.02
6637CC2D1A levelsGCST904685570.02
6638Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T135ECGA0001350.02
6639IL16 levelsGCST904695570.02
6640PARK7 levelsGCST904701590.02
6641SMPD3 levelsGCST904706850.02
6642Triglycerides in medium HDLGCST904986670.02
6643Knee extension strengthGCST903195020.02
6644CD200/CNTNAP2 ratioGCST903137470.02
6645Lysoalkenylphosphatidylethanolamine (P-20:0) levelsGCST900254600.02
6646Polyunsaturated fatty acid levelsGCST905026230.02
6647Graves disease, strict definitionFING000005920.02
6648CASP10/ING1 ratioGCST903136250.02
6649ENAH levelsGCST904691060.02
6650Diastolic blood pressureGCST903102950.02
6651aparc-pial lh area rostralmiddlefrontalGCST900031670.02
6652Sphingomyelin_41:2_[M+H]1+ levelsGCST900603830.02
6653Monoclonal gammopathy of undetermined significanceGCST906247450.02
6654Hippocampal right GC-ML-DG volume (head)GCST902679680.02
6655Free Cholesterol to Total Lipids in Medium VLDL percentageGCST904989880.02
6656aparc-a2009s rh area G-cuneusGCST900033810.02
6657HematocritGCST902786340.02
6658IDP dMRI TBSS ISOVF Posterior corona radiata RGCST900045030.02
6659BA-exvivo lh volume V2GCST900028450.02
6660TACC3/TRIAP1 ratioGCST903159010.02
6661T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128)GCST903206910.02
6662Dronedarone medicationFING000004740.02
6663DBN1 levelsGCST904689500.02
6664TNFRSF8 levelsGCST904709150.02
6665DCTN1/ERBIN ratioGCST903144290.02
6666Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T26ECGA0000260.02
6667LIPF levelsGCST904697800.02
6668DTI TBSS MD Posterior limb of internal capsule RGCST903845900.02
6669Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T145ECGA0001450.02
6670T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26)GCST903208450.02
6671Alzheimer's disease (late onset)GCST0022450.02
6672Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T246ECGU0002460.02
6673UROD levelsGCST904710160.02
6674Treatment/medication code - seretide 50 evohaler | MedicationsUKBB000008580.02
6675Whole body fat-free mass | Impedance measuresUKBB000009150.02
6676SOD1 levelsGCST904707040.02
6677Benign neoplasm of major salivary glandsFING000001570.02
6678LGALS3 levelsGCST900120090.02
6679DHX58 levelsGCST906182380.02
6680CLEC4G/NELL2 ratioGCST903141220.02
6681Sitting height | Body size measuresUKBB000007710.02
6682Triglyceride to phosphoglyceride ratioGCST904999960.02
6683Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST906687390.02
6684ANGPT1/SERPINE1 ratioGCST903132690.02
6685CD300LG/TNFRSF1A ratioGCST903138030.02
6686Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levelsGCST900603070.02
6687NSFL1C/UBAC1 ratioGCST903155650.02
6688Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T159ECGU0001590.02
6689Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T466ECGU0004660.02
6690Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13ECGA0000130.02
6691LEFTY2 levelsGCST904697520.02
6692DTI autoptx L3 ptr r tractGCST903852130.02
6693Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T246ECGA0002460.02
6694DTI autoptx L2 ptr r tractGCST903851860.02
6695T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11)GCST903205740.02
6696Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney diseaseGCST902652740.02
6697ARHGAP25/RNF41 ratioGCST903133450.02
6698CCDC80/CHRDL1 ratioGCST903136700.02
6699Cervical disc disordersFING000002650.02
6700Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T250ECGU0002500.02
6701Thyroxine levelsGCST902002930.02
6702IDP dMRI TBSS MD Corticospinal tract RGCST900040330.02
6703IDP dMRI TBSS L2 Retrolenticular part of internal capsule RGCST900041430.02
6704Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T268ECGU0002680.02
6705Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T155ECGA0001550.02
6706T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 22)GCST903208410.02
6707SSC4D levelsGCST904707470.02
6708T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86)GCST903206490.02
6709Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 7.99_210.09)GCST902913120.02
6710Arterial embolism and thrombosis of lower extremity arteryFING000001060.02
6711AMY2A levelsGCST904682980.02
6712potassium (mean, inv-norm transformed)GCST904763070.02
6713Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T125ECGA0001250.02
6714Mean corpuscular hemoglobin concentrationGCST900023910.02
6715Other cataractFING000009760.02
6716Transient ischemic attackFING000013750.02
6717Phenylacetate levelsGCST901996300.02
6718Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T245ECGU0002450.02
6719IDP dMRI TBSS MD Anterior limb of internal capsule RGCST900040430.02
6720Triglycerides in small VLDLGCST904999170.02
6721Corneal resistance factorGCST903086820.02
6722Rheumatoid arthritisGCST900186900.02
6723Liver enzyme levels (alkaline phosphatase)GCST900134060.02
6724Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T252ECGU0002520.02
6725Hair/balding pattern: Pattern 1 (UKB data field 2395_1)GCST900436160.02
6726DCXR levelsGCST904689640.02
6727Chronic renal failure [CKD] (PheCode 585.3)GCST904761230.02
6728VCAN levelsGCST904710320.02
6729Hypothyroidism (PheCode 244)GCST904756470.02
6730C2 levelsGCST904684970.02
6731SRC/TBL1X ratioGCST903158840.01
6732Other disorders of testis (PheCode 603)GCST904761560.01
6733Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T179ECGU0001790.01
6734AREG levelsGCST904683470.01
6735IDP dMRI ProbtrackX L2 cst lGCST900042810.01
6736ALCAM/ENPP2 ratioGCST903132360.01
6737T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44)GCST903206070.01
6738Free cholesterol in very large HDL (UKB data field 23556)GCST902696530.01
6739IDP dMRI TBSS OD Tapetum RGCST900044480.01
6740Cholesterol levels in very small VLDLGCST905007000.01
6741ENO2/MANF ratioGCST903146620.01
6742RBKS levelsGCST904704330.01
6743T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90)GCST903209090.01
6744CD209/CLEC4G ratioGCST903137500.01
6745Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180ECGU0001800.01
6746Non-insulin-dependent diabetes mellitus | Diabetes mellitusUKBB000005240.01
6747RNASET2 levelsGCST904704810.01
6748Macular degeneration, dry (PheCode 362.21)GCST904758510.01
67495alpha-pregnan-3beta,20beta-diol monosulfate (1) levelsGCST901998530.01
6750Acylcarnitine (18:2) levelsGCST900246230.01
6751Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T5ECGA0000050.01
6752aparc-DKTatlas lh volume insulaGCST900028930.01
6753Inguinal herniaFING000006810.01
6754DIABLO/GRAP2 ratioGCST903144660.01
6755Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T175ECGA0001750.01
6756Ankle spacing width (left) | Bone-densitometry of heelUKBB000000330.01
6757Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57)GCST906687350.01
6758Dry age-related macular degeneration (includes geographic atrophy)FING000004800.01
6759Diverticulosis (PheCode 562.1)GCST904760760.01
6760Degenerative skin conditions and other dermatoses (PheCode 702)GCST904762020.01
6761CTRC/PLA2G1B ratioGCST903143100.01
6762Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T265ECGA0002650.01
6763Non-HDL cholesterol levelsGCST902396690.01
6764HypothyroidismGCST903193200.01
6765Chronic Kidney Disease, Stage III (PheCode 585.33)GCST904761280.01
6766Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T247ECGU0002470.01
6767HTRA2/SIAE ratioGCST903150970.01
6768Red cell distribution widthGCST0068040.01
6769IL1R1 levelsGCST904255630.01
6770MSMB levelsGCST904699490.01
6771Hip indexGCST0122290.01
6772Colorectal cancer (PheCode 153)GCST904755660.01
6773MS-disease / Multiple SclerosisFING000008390.01
6774Fibroblastic disorders | Other soft tissue disordersUKBB000002460.01
6775KeratitisFING000007080.01
6776Triglycerides to Total Lipids in Small HDL percentageGCST904995430.01
6777Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T269ECGU0002690.01
6778Bicarbonate (minimum, inv-norm transformed)GCST904751500.01
6779ACY1/SCLY ratioGCST903131650.01
6780Corns and callosities (PheCode 700)GCST904761960.01
6781T1 FreeSurfer DKT rh lateraloccipital areaGCST903842950.01
6782Hip circumference adjusted for BMIGCST900200280.01
6783Sulcal opening distance of the right calloso-marginal posterior fissureGCST901049460.01
6784T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108)GCST903209270.01
6785Phosphoglycerides levelsGCST900929380.01
6786Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T176ECGA0001760.01
6787CancerGCST900860520.01
6788Skin cancerGCST904755750.01
6789ATP5IF1/METAP1D ratioGCST903133910.01
6790ASAH2 levelsGCST904683740.01
6791CST6/NECTIN4 ratioGCST903143030.01
6792Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T166ECGA0001660.01
6793SRSF7 levelsGCST902427710.01
6794Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T143ECGA0001430.01
6795CCN2/TPP1 ratioGCST903137180.01
6796ACE2/MME ratioGCST903131540.01
6797Prostate cancerGCST900186850.01
6798Cholesteryl Esters in Small LDLGCST904995780.01
6799Glycated hemoglobin levelsGCST900022430.01
6800Ventral herniaFING000014280.01
6801Acquired foot deformities (PheCode 735)GCST904762470.01
6802Basal cell carcinoma (MTAG)GCST901374110.01
6803DBNL/HSPA1A ratioGCST903144180.01
6804USP8 levelsGCST904710220.01
6805aparc-Desikan rh area parsopercularisGCST900031240.01
6806Carboplatin drug response (IC50)GCST900117830.01
6807Degree of unsaturationGCST905022300.01
6808Abnormal results of function study of thyro (PheCode 246.7)GCST904756540.01
6809CD58/TYRO3 ratioGCST903138560.01
6810Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T216ECGU0002160.01
6811Treatment or medication use - metformin (UKB data field 20003_1140884600)GCST900422450.01
6812TBC1D23 levelsGCST904708100.01
6813Retention of urineFING000012570.01
6814CRIM1/NRP2 ratioGCST903142610.01
6815GoutGCST903997010.01
6816SMTN levelsGCST904706890.01
6817Hair colour (natural, before greying) - Black | Sun exposureUKBB000002950.01
6818MTHFSD levelsGCST904699560.01
6819Waist circumference adjusted for body mass indexGCST0122260.01
6820Glycine levelsGCST904973150.01
6821ALPP levelsGCST904682860.01
6822MSRA/SNAP29 ratioGCST903155000.01
6823Triglycerides in medium HDLGCST904986720.01
6824BAG3 levelsGCST904684160.01
6825Ectopic pregnancyFING000004870.01
6826Triglycerides in IDLGCST904976710.01
6827Retinal venular widthGCST902704000.01
6828IDP dMRI TBSS FA Cerebral peduncle RGCST900038910.01
6829COL1A1/SOST ratioGCST903141720.01
6830PLA2G1B levelsGCST904702460.01
6831Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T149ECGA0001490.01
6832EPHB4 levelsGCST904691320.01
6833Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditionsUKBB000001000.01
6834Glaucoma (multi-trait analysis)GCST0097220.01
6835KIRREL2/PLA2G1B ratioGCST903152510.01
6836DTI autoptx FA ifo l tractGCST903851240.01
6837Ulcerative rectosigmoiditisFING000013940.01
6838Histidine levelsGCST904974790.01
6839Contracture of palmar fascia [Dupuytren's disease] | musculoskeletalUKBB000001460.01
6840Blood cell traits latent factor 2 (red cell)GCST905592440.01
6841NRCAM/PCDH17 ratioGCST903155530.01
6842EmphysemaFING000004960.01
6843Ratio of polyunsaturated fatty acids to total fatty acidsGCST900929410.01
6844PDE5A levelsGCST904701870.01
6845Prostate cancerGCST0060850.01
6846REST UKBBICA NET100 1111GCST903869650.01
6847COL6A3/OGN ratioGCST903141770.01
6848Volume of left paralaminar nucleusGCST904748950.01
68491-stearoyl-2-arachidonoyl-GPC (18:0/20:4) metabolite levelGCST906156700.01
6850HypothyroidismGCST902041670.01
6851Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T82ECGU0000820.01
6852wg rh intensity-contrast lateralorbitofrontalGCST900038380.01
6853Breast sizeGCST0066550.01
6854IDP T1 FAST ROIs R planum temporaleGCST900025420.01
6855HNMT levelsGCST904694680.01
6856Cardiometabolic multimorbidityGCST902747230.01
6857DTI TBSS L3 Anterior corona radiata RGCST903845460.01
6858Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T245ECGA0002450.01
6859Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T143ECGU0001430.01
6860T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124)GCST903209430.01
6861ITGB1BP2/USP8 ratioGCST903152230.01
6862Mild age-related type 2 diabetesGCST900264160.01
6863IDP dMRI ProbtrackX L3 ar rGCST900043010.01
6864Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T272ECGA0002720.01
6865DPT levelsGCST904690360.01
6866TSHB levelsGCST904709740.01
6867Whole body water mass | Impedance measuresUKBB000009160.01
6868CEACAM1/GGT1 ratioGCST903140000.01
6869PCDH12 levelsGCST904701680.01
6870Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T474ECGU0004740.01
6871aparc-DKTatlas rh volume parstriangularisGCST900029110.01
6872Hippocampal left GC-ML-DG volume (head)GCST902679460.01
6873Cis-4-decenoylcarnitine (C10:1) metabolite levelGCST906157290.01
6874Thyroid stimulating hormone levelsGCST902963330.01
6875Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressureUKBB000003770.01
6876Triglycerides | Blood biochemistryUKBB000008610.01
6877Rectal cancerGCST900118100.01
6878Polycythemia, secondary (PheCode 289.8)GCST904758220.01
6879Mean corpuscular haemoglobin concentration (UKB data field 30060)GCST904680850.01
6880BAIAP2/MME ratioGCST903134530.01
6881GRPEL1 levelsGCST904694050.01
6882Cholesteryl esters in very large VLDLGCST905005520.01
6883Pregnenediol sulfate (C21H34O5S) levelsGCST901998610.01
6884Calculus of lower urinary tractFING000002370.01
6885CD244/EDAR ratioGCST903137640.01
6886DIABLO levelsGCST904689940.01
6887Acquired hypothyroidism (PheCode 244.2)GCST904756500.01
6888Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T134ECGA0001340.01
6889PARP1/TCL1A ratioGCST903156020.01
6890Degree of unsaturationGCST905027530.01
6891Other localized connective tissue disordersFING000010660.01
6892Forced vital capacity FVC Z score (UKB data field 20257)GCST904681670.01
6893Cancer (UKB data field 2453)GCST900436280.01
6894DTI TBSS MD Superior fronto-occipital fasciculus RGCST903846140.01
6895Estimated glomerular filtration rate, cystain C | Other measurementUKBB000002100.01
6896aparc-DKTatlas rh volume lateraloccipitalGCST900029020.01
6897Allergic conjunctivitisFING000000670.01
6898Triglycerides in small HDLGCST904995160.01
6899Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T15ECGU0000150.01
6900FURIN/IGSF3 ratioGCST903148850.01
6901Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T251ECGU0002510.01
6902Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480ECGU0004800.01
6903Endometriosis of ovaryFING000005010.01
6904Primary open angle glaucoma (PheCode 365.11)GCST904758750.01
6905Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T263ECGU0002630.01
6906Kidney volumeGCST900166700.01
6907Autoimmune hyperthyroidismFING000001340.01
6908CABP2 levelsGCST904685190.01
6909hemoglobin (minimum, inv-norm transformed)GCST904753800.01
6910MANF/PRDX5 ratioGCST903153650.01
6911Volume of left whole amygdalaGCST904749880.01
6912Takes medication for Sleep apnea?GCST904752580.01
69135alpha-pregnan-3beta,20alpha-diol disulfate levelsGCST901998380.01
6914Hypothyroidism NOS (PheCode 244.4)GCST904756530.01
6915DTI TBSS MD Anterior limb of internal capsule LGCST903845890.01
6916Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T150ECGA0001500.01
6917CASP8/SEPTIN9 ratioGCST903136580.01
6918IDP SWI T2star left putamenGCST900038670.01
6919wg lh intensity-contrast entorhinalGCST900037970.01
6920T1 CAT volume R InsularCortexGCST903840030.01
6921BCR/ITGB1BP2 ratioGCST903134940.01
6922Hallux valgus (Bunion) | musculoskeletalUKBB000002990.01
6923CXCL11 levelsGCST902747810.01
6924Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471ECGU0004710.01
6925Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T461ECGU0004610.01
6926Vanillactate levelsGCST901999780.01
6927IDP T1 FAST ROIs L hippocampusGCST900025550.01
6928Forced vital capacity (FVC) | SpirometryUKBB000002540.01
6929Calculus of ureter (PheCode 594.3)GCST904761470.01
6930ITGB1BP2/STAT5B ratioGCST903152200.01
6931Deep venous thrombosisGCST904681220.01
6932T1 FreeSurfer DK rh cuneus volumeGCST903857610.01
6933F2R/ITGB1BP2 ratioGCST903147310.01
6934Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T279ECGA0002790.01
6935SPESP1 levelsGCST904707200.01
6936Volume of left cortical nucleusGCST904748860.01
6937Pulse pressureGCST903017010.01
6938GlaucomaFING000005770.01
6939Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T12ECGU0000120.01
6940GLB1/PCSK9 ratioGCST903149330.01
6941Delta body mass index (difference between ECG-predicted and measured)GCST904290620.01
6942Hernia of abdominal wallFING000006170.01
6943Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T247ECGA0002470.01
6944GKN2 levelsGCST900894130.01
6945CCL20 levelsGCST900120770.01
6946Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T21ECGA0000210.01
6947IGFBP2 levelsGCST904695280.01
6948ROR1/THBD ratioGCST903157860.01
6949Forced expiratory volume in 1 second FEV1 Z score (UKB data field 20256)GCST904681660.01
6950EndometriosisGCST900186190.01
6951DBI/TMSB10 ratioGCST903144140.01
6952NPY/SMOC1 ratioGCST903155510.01
6953Phosphatidylethanolamine (18:0_18:1) levelsGCST900249770.01
6954NUCB2/RSPO3 ratioGCST903155750.01
6955Free cholesterol in large LDLGCST904979810.01
6956PCSK9 levelsGCST904281100.01
6957Phospholipid levels in very small VLDLGCST900930360.01
6958Facial skin colour (CIELAB index b* value)GCST900200560.01
6959Volume of right paralaminar nucleusGCST904750480.01
6960RIDA levelsGCST904704690.01
6961aparc-pial rh area parsopercularisGCST900031910.01
6962CPXM1/VEGFC ratioGCST903142230.01
6963LifespanGCST905518860.01
6964T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72)GCST903208910.01
6965wg rh intensity-contrast lateraloccipitalGCST900038370.01
6966Free cholesterol levels in medium HDLGCST901326790.01
6967Interpolated Age of participant when operation took place | OperationsUKBB000003700.01
6968MMP12 levelsGCST900120700.01
6969IFNLR1 levelsGCST904695180.01
6970IDP dMRI TBSS FA Uncinate fasciculus RGCST900039210.01
6971DPP6 levelsGCST904690340.01
6972Takes medication for gout?GCST904763820.01
6973CLMP/TGFBR2 ratioGCST903141350.01
6974Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T36ECGA0000360.01
6975AHSP/BLVRB ratioGCST903132140.01
6976TCL1A levelsGCST904708170.01
6977EPO levelsGCST904691360.01
6978CD63/EDAR ratioGCST903138640.01
6979DTI TBSS MD Posterior limb of internal capsule LGCST903845910.01
6980Cysteine-glutathione disulfide levelsGCST901997840.01
6981Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T127ECGA0001270.01
6982Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8 (more control exclusions)FING000006940.01
6983DNAJA2/SCAMP3 ratioGCST903145070.01
6984Pancreas iron contentGCST900166760.01
6985Nasal polypFING000008580.01
6986TYMP levelsGCST904709960.01
6987Blood cell traits latent factor 20 (red cell)GCST905592620.01
6988AMOT levelsGCST904682950.01
6989CD83/TREM2 ratioGCST903139080.01
6990MRPL33 levelsGCST906179860.01
6991GPA33 levelsGCST904693850.01
6992PDZK1 levelsGCST904702030.01
6993Polyunsaturated fatty acids to total fatty acids percentageGCST905026320.01
6994Graves' disease (PheCode 242.1)GCST904756440.01
6995T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127)GCST903206900.01
6996Glaucoma suspectFING000005790.01
6997Bacterial pneumoniaeFING000001390.01
6998Gestational [pregnancy-induced] oedema and proteinuria without hypertensionFING000005720.01
6999Triglycerides in small HDLGCST904995190.01
7000CD209/CLEC14A ratioGCST903137490.01